FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cefepime Injection
Status: Discontinuation
»Therapeutic Categories: Anti-Infective; Pediatric

Expand all

Apotex Corp. (Revised 01/11/2018)

Company Contact Information:
800-706-5575

Presentation Posting Date Related Information
Cefepime for Injection, USP 1 gm (10 Vials) (NDC 60505-6030-4) N/A Discontinuation of the manufacture of the drug
Cefepime for Injection, USP 2 gm (10 Vials)(NDC 60505-6031-4) N/A Discontinuation of the manufacture of the drug
Cefepime for injection, USP 1 gm (10 Vials) (NDC 60605-0834-04) N/A Discontinuation of the manufacture of the drug
Cefepime for injection, USP 2 gm (10 Vials) (NDC 60505-0681-4) N/A Discontinuation of the manufacture of the drug
Cefepime for injection, USP 1 gm (1 Vial) (NDC 60505-0834-00) N/A Discontinuation of the manufacture of the drug
Cefepime for injection, USP 2 gm (10 Vials) (NDC 60505-0681-0) N/A Discontinuation of the manufacture of the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English